PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.8522
-0.0118 (-1.37%)
May 13, 2025, 4:00 PM - Market closed

PMV Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-60.88-58.71-68.96-73.32-57.85-34.44
Upgrade
Depreciation & Amortization
0.821.141.260.320.310.32
Upgrade
Loss (Gain) From Sale of Assets
0.070.06----
Upgrade
Loss (Gain) From Sale of Investments
-4.58-5.37-5.39-0.630.550.15
Upgrade
Stock-Based Compensation
7.778.8712.3810.25.341.93
Upgrade
Other Operating Activities
4.394.31-0.370.240.960.14
Upgrade
Change in Accounts Payable
2.743.340.24-0.390.19-1.23
Upgrade
Change in Other Net Operating Assets
-3.69-4.935.19-0.183.930.39
Upgrade
Operating Cash Flow
-53.36-51.28-55.66-63.76-46.57-32.74
Upgrade
Capital Expenditures
-0.07-0.66-0.96-7.98-1.35-0.15
Upgrade
Sale of Property, Plant & Equipment
0.250.25----
Upgrade
Investment in Securities
55.7153.76-49.586.62-142.2428.06
Upgrade
Investing Cash Flow
55.953.35-50.55-1.37-143.5827.91
Upgrade
Issuance of Common Stock
0.320.3135.580.962.02243.54
Upgrade
Other Financing Activities
------20.57
Upgrade
Financing Cash Flow
0.320.3135.580.962.02292.97
Upgrade
Foreign Exchange Rate Adjustments
0.01-0.040.03---
Upgrade
Net Cash Flow
2.872.35-70.59-64.17-188.13288.14
Upgrade
Free Cash Flow
-53.43-51.94-56.62-71.74-47.92-32.89
Upgrade
Free Cash Flow Per Share
-1.03-1.01-1.18-1.57-1.06-2.29
Upgrade
Cash Income Tax Paid
----0.020.01
Upgrade
Levered Free Cash Flow
-45.87-44.68-32.94-48.97-27.51-20.58
Upgrade
Unlevered Free Cash Flow
-45.87-44.68-32.94-48.97-27.51-20.58
Upgrade
Change in Net Working Capital
0.371.01-4.473.34-4.620.85
Upgrade
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q